Low-grade serous ovarian cancer
1 paper
- Humans1
Trial sponsors
Company1 trialPhase 3270 people
Company1 trialPhase 1/2890 people
Memorial Sloan Kettering Cancer Center
1 trialPhase 220 people
Latest
1 in 12 monthsJournal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences
Causal effects of telomere length on ovarian tumor risk: Insights from genetic evidence
Mendelian randomisation in peopleTelomerase and telomere maintenance